Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)
Grant Opportunity Analysis
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment" (R61/R33 Basic Experimental Studies with Humans Required). This initiative aims to encourage exploratory and developmental research focused on identifying and validating novel targets for non-invasive brain stimulation (NIBS) and understanding the neurobiological and cognitive responses that precede clinical outcomes such as reduced cravings or substance use. The funding is critical for advancing innovative methodologies in substance use disorder (SUD) research, with a maximum award of $600,000 available for the R61 phase over two years, and applications are due by August 14, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-034.html.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.